BNP Paribas Financial Markets’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.2K | Buy |
5,541
+4,608
| +494% | +$18.4K | ﹤0.01% | 3741 |
|
|
2025
Q1 | $2.97K | Buy |
933
+72
| +8% | +$229 | ﹤0.01% | 4095 |
|
|
2024
Q4 | $4.61K | Sell |
861
-2,249
| -72% | -$12K | ﹤0.01% | 4089 |
|
|
2024
Q3 | $16.4K | Buy |
+3,110
| New | +$16.4K | ﹤0.01% | 3036 |
|
|
2023
Q1 | – | Sell |
-232
| Closed | -$197 | – | 3241 |
|
|
2022
Q4 | $197 | Buy |
232
+133
| +134% | +$113 | ﹤0.01% | 3262 |
|
|
2022
Q3 | $81 | Sell |
99
-1,125
| -92% | -$920 | ﹤0.01% | 3943 |
|
|
2022
Q2 | $1.21K | Buy |
+1,224
| New | +$1.21K | ﹤0.01% | 3257 |
|
|
2021
Q1 | – | Sell |
-4
| Closed | -$14 | – | 3427 |
|
|
2020
Q4 | $14 | Hold |
4
| – | – | ﹤0.01% | 3449 |
|
|
2020
Q3 | $16 | Hold |
4
| – | – | ﹤0.01% | 3533 |
|
|
2020
Q2 | $11 | Sell |
4
-75
| -95% | -$206 | ﹤0.01% | 3643 |
|
|
2020
Q1 | $167 | Hold |
79
| – | – | ﹤0.01% | 3573 |
|
|
2019
Q4 | $430 | Sell |
79
-1,727
| -96% | -$9.4K | ﹤0.01% | 3588 |
|
|
2019
Q3 | $5.44K | Hold |
1,806
| – | – | ﹤0.01% | 3611 |
|
|
2019
Q2 | $6.75K | Sell |
1,806
-1,337
| -43% | -$5K | ﹤0.01% | 3565 |
|
|
2019
Q1 | $12.6K | Buy |
3,143
+2,934
| +1,404% | +$11.8K | ﹤0.01% | 3402 |
|
|
2018
Q4 | $767 | Sell |
209
-209
| -50% | -$767 | ﹤0.01% | 3276 |
|
|
2018
Q3 | $3.59K | Sell |
418
-66
| -14% | -$566 | ﹤0.01% | 3490 |
|
|
2018
Q2 | $5.31K | Sell |
484
-1,225
| -72% | -$13.5K | ﹤0.01% | 3424 |
|
|
2018
Q1 | $19.7K | Buy |
1,709
+13
| +0.8% | +$150 | ﹤0.01% | 3342 |
|
|
2017
Q4 | $17.6K | Buy |
1,696
+1,126
| +198% | +$11.7K | ﹤0.01% | 3304 |
|
|
2017
Q3 | $9.09K | Buy |
570
+190
| +50% | +$3.03K | ﹤0.01% | 3333 |
|
|
2017
Q2 | $4.6K | Buy |
380
+374
| +6,233% | +$4.53K | ﹤0.01% | 3438 |
|
|
2017
Q1 | $125 | Sell |
6
-37
| -86% | -$771 | ﹤0.01% | 3396 |
|
|
2016
Q4 | $615 | Sell |
43
-182
| -81% | -$2.6K | ﹤0.01% | 3380 |
|
|
2016
Q3 | $3.7K | Buy |
225
+94
| +72% | +$1.55K | ﹤0.01% | 3427 |
|
|
2016
Q2 | $1.87K | Buy |
+131
| New | +$1.87K | ﹤0.01% | 3452 |
|